bf/NASDAQ:CNTA_icon.jpeg

NASDAQ:CNTA

Centessa Pharmaceuticals plc

  • Stock

USD

Last Close

22.84

06/11 21:01

Market Cap

994.77M

Beta: -

Volume Today

595.10K

Avg: 172.13K

PE Ratio

−5.00

PFCF: −4.38

OverviewFinancialsAPI

    Description

    Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2.5-2-1.5-1-0.52020-03-312021-06-012022-03-302022-12-312024-05-102025-03-27

    Revenue (Estimate*)

    1M2M3M4M5M6M7M2020-03-312021-06-012022-03-302022-12-312024-05-102025-03-27

    *Estimate based on analyst consensus